Kyowa Kirin (OTCPK:KYKOF) launches
NOURIANZ (istradefylline), an adenosine receptor antagonist in U.S. as
an adjunctive treatment to levodopa/carbidopa in adult patients with
Parkinson’s disease (PD) experiencing “off” episodes.
https://seekingalpha.com/news/3505724-kyowa-kirins-nourianz-now-available-u-s
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.